Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825

Michael E. Scheurer, Renke Zhou, Mark R. Gilbert, Melissa L. Bondy, Erik P. Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M. Wendland, Emad F. Youssef, Volker W. Stieber, Ritsuko R. Komaki, John C. Flickinger, Lawrence C. Kenyon, H. Ian Robins, Grant K. Hunter, Ian R. Crocker, Samuel T. Chao, Stephanie L. Pugh, Terri S. Armstrong

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825'. Together they form a unique fingerprint.

Medicine & Life Sciences